From Free to Free Market: Cost Recovery in Federally Funded Clinical Research
Science Translational Medicine on posted an article, “From Free to Free Market: Cost Recovery in Federally Funded Clinical Research.” The authors examined “some of the hybrid academic-business models in 19 clinical research centers within the Clinical and Translational Science Award consortium that are emerging to address the issue of cost recovery of clinical research that is supported by the United States federal government.” The authors identified “initiatives that have succeeded or failed, essential supporting and regulatory components, and lessons learned from experience to design an optimal cost recovery model and a timeline for its implementation.” (A subscription may be necessary for access.)
http://tinyurl.com/6oksb32
